Stock listing

GNLX Stock Price, News, Filings & Events — Genelux Corporation

Selected listing: GNLX · NASDAQ · USD · US

This page tracks Genelux Corporation's GNLX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GNLX:NASDAQ. GNLX:NASDAQ is the stock-level entry point for investors researching Genelux Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genelux Corporation, trading under the ticker GNLX, is a public company based in the United States with a market capitalization of approximately $129.6 million. The company focuses on developing innovative therapies for cancer treatment. Genelux aims to advance its proprietary technologies to improve patient outcomes in oncology.